ATOSSA THERAPEUTICS, INC. Deferred Tax Liabilities, Property, Plant and Equipment
ATOSSA THERAPEUTICS, INC. (ATOS) had Deferred Tax Liabilities, Property, Plant and Equipment of $0 as of 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment · last filed 2024-04-01
- 2023-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $0.00.
- 2022-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $1.00K.
- 2021-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $1.00K.
- 2020-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $0.00.
| Period end | Deferred Tax Liabilities, Property, Plant and Equipment |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-04-01 |
| 2022-12-31 | $1.00K 10-K · filed 2024-04-01 |
| 2021-12-31 | $1.00K 10-K · filed 2023-03-22 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-28 |
| 2014-12-31 | $3.20K 10-K · filed 2015-03-30 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |